NVNovartis NVS · NYSE
$150.58 +0.13% (+$0.20)
- Market cap
- $285.8B
- Enterprise value
- $327.2B
- P/E
- 22.4x
- Forward P/E
- 16.6x
- PEG
- 1.1x
- P/S
- 5.1x
- P/FCF
- 18.1x
- EV/EBITDA
- 14.7x
- ROIC
- 13.9%
- Bruto marža
- 74.4%
- Neto marža
- 22.9%
- Dividend yield
- 3.15%
- Payout ratio
- 70.6%
- Neto dolg/EBITDA
- 1.9x
- Beta
- 0.42
- Free float
- 96.3%
O podjetju
Novartis AG is a Swiss global pharmaceutical company with a broad portfolio of medicines and healthcare products. The company is one of the leading players in the pharmaceutical industry and operates worldwide. Novartis focuses on the development, manufacturing, and distribution of innovative medicines in various therapeutic areas, including oncology, cardiology, ophthalmology, neurology, and others. The company also specializes in the production and sale of generic drugs. Novartis dedicates significant efforts to research and development of new treatment options to help improve the quality of life for patients around the world. The company actively collaborates with medical professionals and institutions to ensure the best care for patients. Novartis AG (NVS) shares are an attractive choice for investors who follow the pharmaceutical industry and seek investment opportunities in a reputable company with a rich medical portfolio and a long history of innovation.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vasant Narasimhan
Employees
75,267
Headquarters
Basel
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke